Main Industry
Biotechnology
Main Product/Service
ExoOne Bio. Co., Ltd. is dedicated to the research and development of novel drugs for degenerative diseases, aiming to enhance human health and usher in a new era of therapeutic efficacy. The indications for these new drugs include optic nerve degeneration, osteoarthritis, and chronic kidney disease, among others.
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83414673
Status
Active
Number of Employees
0
Total Paid-in
Capital
284,937,820 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ExoOne Bio. Co., Ltd. is Taiwan's first exosome new drug development company, founded at the end of 2020 by Dr. Tzou-Yien Lin, the former Minister of the Ministry of Health and Welfare. Leveraging its outstanding medical background and rich experience across industry, government, and academia, ExoOne Bio. Co., Ltd. has laid a solid foundation for its development, gradually establishing a unique core technology for exosome purification, identification, and isolation. Its achievements surpass international standards and have been recognized with multiple patents.
In the future, ExoOne Bio. Co., Ltd. will take it as its mission to utilize high-quality exosome biotechnology products to treat degenerative diseases and maintain healthy aging, aspiring to become a global leader in anti-aging and rejuvenation.
In the future, ExoOne Bio. Co., Ltd. will take it as its mission to utilize high-quality exosome biotechnology products to treat degenerative diseases and maintain healthy aging, aspiring to become a global leader in anti-aging and rejuvenation.
The content above was translated by Ai
